Literature DB >> 10702792

NF-kappa B is required for H-ras oncogene induced abnormal cell proliferation and tumorigenesis.

H Jo1, R Zhang, H Zhang, T A McKinsey, J Shao, R D Beauchamp, D W Ballard, P Liang.   

Abstract

Oncogenic mutations in ras lead to constitutive activation of downstream signaling pathways that modulate the activities of transcription factors. In turn, these factors control the expression of a subset of genes responsible for neoplastic cell transformation. Recent studies suggest that transcription factor NF-kappa B contributes to cell transformation by inhibiting the cell death signal activated by oncogenic Ras. In this study, inhibition of NF-kappa B activity by forced expression of a super-repressor form of I kappa B alpha, the major inhibitor of NF-kappa B, markedly decreased the growth rate, saturation density and tumorigenicity of oncogenic H-Ras transformed rat embryo fibroblasts. Such clonally isolated cells overexpressing I kappa B alpha super-repressor not only were viable but also exhibited no sign of spontaneous apoptosis. Inhibition of NF-kappa B in these cells was functionally demonstrated by both the loss of cytokine induced DNA binding activity and a profoundly increased sensitivity to cell death in response to TNF-alpha treatment. In contrast, inhibition of NF-kappa B activity in non-transformed fibroblasts had minimal effect on growth, but rendered the cells resistant to a subsequent transformation by H-ras oncogene. Similar results were also obtained with rat intestinal epithelial cells harboring an inducible ras oncogene. Taken together, these findings suggest that NF-kappa B activity is essential for abnormal cell proliferation and tumorigenicity activated by the ras oncogene and highlight an alternative functional role for NF-kappa B in oncogenic Ras-mediated cell transformation that is distinct from its anti-apoptotic activity. Oncogene (2000) 19, 841 - 849.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10702792     DOI: 10.1038/sj.onc.1203392

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  22 in total

1.  Opposing roles of the extracellular signal-regulated kinase and p38 mitogen-activated protein kinase cascades in Ras-mediated downregulation of tropomyosin.

Authors:  Janiel M Shields; Heena Mehta; Kevin Pruitt; Channing J Der
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

2.  Conditional ablation of Ikkb inhibits melanoma tumor development in mice.

Authors:  Jinming Yang; Ryan Splittgerber; Fiona E Yull; Sara Kantrow; Gregory D Ayers; Michael Karin; Ann Richmond
Journal:  J Clin Invest       Date:  2010-06-07       Impact factor: 14.808

3.  Mutant human cells with constitutive activation of NF-kappaB.

Authors:  Swati S Sathe; Nywana Sizemore; Xiaoxia Li; Kalpa Vithalani; Mairead Commane; Shannon M Swiatkowski; George R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-22       Impact factor: 11.205

4.  Rapamycin potentiates transforming growth factor beta-induced growth arrest in nontransformed, oncogene-transformed, and human cancer cells.

Authors:  Brian K Law; Anna Chytil; Nancy Dumont; Elizabeth G Hamilton; Mary E Waltner-Law; Mary E Aakre; Cassondra Covington; Harold L Moses
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

5.  Inhibition of cell transformation by sulindac sulfide is confined to specific oncogenic pathways.

Authors:  Manish Gala; Ronggai Sun; Vincent W Yang
Journal:  Cancer Lett       Date:  2002-01-10       Impact factor: 8.679

6.  [Effects of farnesyltransferase silencing on the migration and invasion of tongue squamous cell carcinoma].

Authors:  Shan-Gui Sheng; Ya-Nan Wang; Shao-Ru Wang; Kai Zhao; Yun-Ying Wang; Xiao-Na Xu; Qi-Min Wang; Lei Tong; Zheng-Gang Chen
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2020-04-01

7.  Lysyl oxidase inhibits ras-mediated transformation by preventing activation of NF-kappa B.

Authors:  Sébastien Jeay; Stefania Pianetti; Herbert M Kagan; Gail E Sonenshein
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

8.  Cancer cell-derived clusterin modulates the phosphatidylinositol 3'-kinase-Akt pathway through attenuation of insulin-like growth factor 1 during serum deprivation.

Authors:  Hakryul Jo; Yonghui Jia; Kulandayan K Subramanian; Hidenori Hattori; Hongbo R Luo
Journal:  Mol Cell Biol       Date:  2008-05-05       Impact factor: 4.272

9.  Chronic NF-kappaB activation delays RasV12-induced premature senescence of human fibroblasts by suppressing the DNA damage checkpoint response.

Authors:  Christina Batsi; Soultana Markopoulou; George Vartholomatos; Ioannis Georgiou; Panagiotis Kanavaros; Vassilis G Gorgoulis; Kenneth B Marcu; Evangelos Kolettas
Journal:  Mech Ageing Dev       Date:  2009-05-03       Impact factor: 5.432

Review 10.  NF-kappaB in mammary gland development and breast cancer.

Authors:  Yixue Cao; Michael Karin
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-04       Impact factor: 2.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.